Tiziana Life Sciences announces positive results from studies using nasal anti-CD3 mAb in traumatic spinal cord injury: New York Saturday, January 25, 2025, 13:00 Hrs [IST] Tizian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback